North America Bioprocessing Market
The North America Bioprocessing Market size was valued at US$ 12,440.60 Mn in 2023 and is projected to reach US$ 35,950.43 Mn by 2031, growing at a CAGR of 14.2% during 2023 - 2031.
Report Coverage
- Product: Instruments and Consumables & Accessories
- Scale of Operation: Commercial Operations and Clinical Operations
- Application: Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy
- End User: Biopharmaceutical Companies, Contract Manufacturing Organization
US$ 12,440.60 Mn
Market size in 2023
US$ 35,950.43 Mn
Market Size by 2031
14.2%
CAGR, 2023 - 2031
2024-2031
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Bioprocessing Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Bioprocessing Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Bioprocessing Market Regional Analysis
6.2 North America Bioprocessing Market Revenue 2021-2031 (US$ Million)
6.3 North America Bioprocessing Market Forecast Analysis
7. North America Bioprocessing Market Analysis – by Product
7.1 Instruments and Consumables & Accessories
- 7.1.1 Overview
- 7.1.2 Instruments and Consumables & Accessories: North America Bioprocessing Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. North America Bioprocessing Market Analysis – by Scale of Operation
8.1 Commercial Operations and Clinical Operations
- 8.1.1 Overview
- 8.1.2 Commercial Operations and Clinical Operations: North America Bioprocessing Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. North America Bioprocessing Market Analysis – by Application
9.1 Monoclonal Antibodies
- 9.1.1 Overview
- 9.1.2 Monoclonal Antibodies: North America Bioprocessing Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Vaccines
- 9.2.1 Overview
- 9.2.2 Vaccines: North America Bioprocessing Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Recombinant Protein
- 9.3.1 Overview
- 9.3.2 Recombinant Protein: North America Bioprocessing Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.4 Cell & Gene Therapy
- 9.4.1 Overview
- 9.4.2 Cell & Gene Therapy: North America Bioprocessing Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. North America Bioprocessing Market – North America Analysis
10.1 Overview
10.2 North America- 10.2.1 North America Bioprocessing Market Breakdown, by Key Country, 2024 and 2031 (%)
- 10.2.1.1 North America Bioprocessing Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 US: North America Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.1.1 US: North America Bioprocessing Market Breakdown, by Product
- 10.2.1.1.2 US: North America Bioprocessing Market Breakdown, by Scale of Operation
- 10.2.1.1.3 US: North America Bioprocessing Market Breakdown, by Application
- 10.2.1.2 Canada: North America Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.2.1 Canada: North America Bioprocessing Market Breakdown, by Product
- 10.2.1.2.2 Canada: North America Bioprocessing Market Breakdown, by Scale of Operation
- 10.2.1.2.3 Canada: North America Bioprocessing Market Breakdown, by Application
- 10.2.1.3 Mexico : North America Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.3.1 Mexico : North America Bioprocessing Market Breakdown, by Product
- 10.2.1.3.2 Mexico : North America Bioprocessing Market Breakdown, by Scale of Operation
- 10.2.1.3.3 Mexico : North America Bioprocessing Market Breakdown, by Application
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Getinge AB
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Thermo Fisher Scientific Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Sartorius AG
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Corning Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Bio-Rad Laboratories Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Merck KGaA
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 3M Co
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Eppendorf SE
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Repligen Corp
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Entegris Inc
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 Agilent Technologies Inc
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
13.12 Cytiva US LLC.
- 13.12.1 Key Facts
- 13.12.2 Business Description
- 13.12.3 Products and Services
- 13.12.4 Financial Overview
- 13.12.5 SWOT Analysis
- 13.12.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full N Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
